In this Issue:
Cost evaluation in the diagnosis of recurrent ovarian cancer
Surgical staging with borderline ovarian tumours
CSS in the treatment of malignant ovarian germ cell tumours
Treatment of advanced stage ovarian cancer based on biomarkers
Oral contraceptive and reproductive risk factors for ovarian cancer: a family-based analyses
Circulating biomarkers for detection of ovarian cancer & predicting outcomes
Prognostic factors after conservative treatment in patients with stage I serous borderline tumours of the ovary
Japanese Gynecologic Oncology Group 3016 trial: QoL results
2-week vs 6-week interval from debulking surgery to chemotherapy in epithelial ovarian cancer
Impact of PRBCT on survival in epithelial ovarian cancer
Please login below to download this issue (PDF)